Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...

New research finds reduced ELOVL2 enzyme activity speeds up immune cell aging and disrupts genes linked to cancer.

Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food ...

To assess the applicability of the mouse studies to the human immune system, the researchers analyzed ... The CD79B gene and other B cell-related genes affected by ELOVL2 enzymatic activity ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...